SENIOR UNSECURED REVOLVING CREDIT AGREEMENT dated as of December 18, 2012 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA FINANCE SERVICES B.V., TEVA FINANCE SERVICES II B.V., and TEVA CAPITAL SERVICES SWITZERLAND...Credit Agreement • December 20th, 2012 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Credit Agreement (this “Agreement”), dated as of December 18, 2012, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA FINANCE SERVICES B.V., a Curaçao company registered under no. 105859 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao I”), TEVA FINANCE SERVICES II B.V., a Curaçao company registered under no. 119570 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao II”), Teva Capital Services Switzerland GmbH, a company organized under the laws of Switzerland, registered under no-320.4.062.063-3 (“Teva Capital”), the Additional Borrowers party hereto from time to time, the Le
